These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

474 related articles for article (PubMed ID: 19140571)

  • 21. Changes in antithrombin and fibrinogen levels during induction chemotherapy with L-asparaginase in adult patients with acute lymphoblastic leukemia or lymphoblastic lymphoma. Use of supportive coagulation therapy and clinical outcome: the CAPELAL study.
    Hunault-Berger M; Chevallier P; Delain M; Bulabois CE; Bologna S; Bernard M; Lafon I; Cornillon J; Maakaroun A; Tizon A; Padrazzi B; Ifrah N; Gruel Y;
    Haematologica; 2008 Oct; 93(10):1488-94. PubMed ID: 18728028
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Impact of clinical and subclinical hypersensitivity to asparaginase in acute lymphoblastic leukemia.
    Asselin BL; Fisher V
    Clin J Oncol Nurs; 2014 Dec; 18(6):E107-12. PubMed ID: 25427712
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Remission induction therapy for childhood acute lymphoblastic leukaemia: clinical and cellular pharmacology of vincristine, corticosteroids, L-asparaginase and anthracyclines.
    Ronghe M; Burke GA; Lowis SP; Estlin EJ
    Cancer Treat Rev; 2001 Dec; 27(6):327-37. PubMed ID: 11908926
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Myocardial ischemia in a patient with acute lymphoblastic leukemia during L-asparaginase therapy.
    Saviola A; Luppi M; Potenza L; Morselli M; Bresciani P; Ferrari A; Riva G; Torelli G
    Eur J Haematol; 2004 Jan; 72(1):71-2. PubMed ID: 14962268
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A Phase 2 study of L-asparaginase encapsulated in erythrocytes in elderly patients with Philadelphia chromosome negative acute lymphoblastic leukemia: The GRASPALL/GRAALL-SA2-2008 study.
    Hunault-Berger M; Leguay T; Huguet F; Leprêtre S; Deconinck E; Ojeda-Uribe M; Bonmati C; Escoffre-Barbe M; Bories P; Himberlin C; Chevallier P; Rousselot P; Reman O; Boulland ML; Lissandre S; Turlure P; Bouscary D; Sanhes L; Legrand O; Lafage-Pochitaloff M; Béné MC; Liens D; Godfrin Y; Ifrah N; Dombret H;
    Am J Hematol; 2015 Sep; 90(9):811-8. PubMed ID: 26094614
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Successful treatment of acute lymphoblastic leukemia with L-asparaginase-induced intracranial hemorrhage to activated recombinant factor VIIa in a child.
    Ucar C; Caliskan U
    Pediatr Hematol Oncol; 2006 Jun; 23(4):339-45. PubMed ID: 16621776
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A regimen for antithrombin III substitution in patients with acute lymphoblastic leukemia under treatment with L-asparaginase.
    Mattioli Belmonte M; Gugliotta L; Delvos U; Catani L; Vianelli N; Cascione ML; Belardinelli AR; Mottola L; Tura S
    Haematologica; 1991; 76(3):209-14. PubMed ID: 1743591
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cerebrospinal fluid asparagine concentrations after Escherichia coli asparaginase in children with acute lymphoblastic leukemia.
    Woo MH; Hak LJ; Storm MC; Gajjar AJ; Sandlund JT; Harrison PL; Wang B; Pui CH; Relling MV
    J Clin Oncol; 1999 May; 17(5):1568-73. PubMed ID: 10334545
    [TBL] [Abstract][Full Text] [Related]  

  • 29. L-Asparagine depletion levels and L-asparaginase activity in plasma of children with acute lymphoblastic leukemia under asparaginase treatment.
    Tsurusawa M; Chin M; Iwai A; Nomura K; Maeba H; Taga T; Higa T; Kuno T; Hori T; Muto A; Yamagata M;
    Cancer Chemother Pharmacol; 2004 Mar; 53(3):204-8. PubMed ID: 14634792
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Intravenous pegylated asparaginase versus intramuscular native Escherichia coli L-asparaginase in newly diagnosed childhood acute lymphoblastic leukaemia (DFCI 05-001): a randomised, open-label phase 3 trial.
    Place AE; Stevenson KE; Vrooman LM; Harris MH; Hunt SK; O'Brien JE; Supko JG; Asselin BL; Athale UH; Clavell LA; Cole PD; Kelly KM; Laverdiere C; Leclerc JM; Michon B; Schorin MA; Welch JJ; Lipshultz SE; Kutok JL; Blonquist TM; Neuberg DS; Sallan SE; Silverman LB
    Lancet Oncol; 2015 Dec; 16(16):1677-90. PubMed ID: 26549586
    [TBL] [Abstract][Full Text] [Related]  

  • 31. PEG-asparaginase.
    Fu CH; Sakamoto KM
    Expert Opin Pharmacother; 2007 Aug; 8(12):1977-84. PubMed ID: 17696798
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Critical roles of glutamine as nitrogen donors in purine and pyrimidine nucleotide synthesis: asparaginase treatment in childhood acute lymphoblastic leukemia.
    Cory JG; Cory AH
    In Vivo; 2006; 20(5):587-9. PubMed ID: 17091764
    [TBL] [Abstract][Full Text] [Related]  

  • 33. L-asparaginase induced intracranial haemorrhage in acute lymphoblastic leukemia.
    Lim HL; Teo CP; Wong K; Kueh YK
    Singapore Med J; 1998 Feb; 39(2):76-8. PubMed ID: 9652181
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Circumventing the side effects of L-asparaginase.
    Fonseca MHG; Fiúza TDS; Morais SB; Souza TACB; Trevizani R
    Biomed Pharmacother; 2021 Jul; 139():111616. PubMed ID: 33932739
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Antimetabolite-based therapy in childhood T-cell acute lymphoblastic leukemia: a report of POG study 9296.
    Winter SS; Holdsworth MT; Devidas M; Raisch DW; Chauvenet A; Ravindranath Y; Ducore JM; Amylon MD
    Pediatr Blood Cancer; 2006 Feb; 46(2):179-86. PubMed ID: 16007607
    [TBL] [Abstract][Full Text] [Related]  

  • 36. L-asparaginase and venous thromboembolism in acute lymphocytic leukemia.
    Goyal G; Bhatt VR
    Future Oncol; 2015; 11(17):2459-70. PubMed ID: 26274336
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Asparagine and aspartic acid concentrations in bone marrow versus peripheral blood during Berlin-Frankfurt-Münster-based induction therapy for childhood acute lymphoblastic leukemia.
    Steiner M; Hochreiter D; Kasper DC; Kornmüller R; Pichler H; Haas OA; Pötschger U; Hutter C; Dworzak MN; Mann G; Attarbaschi A
    Leuk Lymphoma; 2012 Sep; 53(9):1682-7. PubMed ID: 22356135
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Is asparaginase a critical component in the treatment of acute lymphoblastic leukemia?
    Douer D
    Best Pract Res Clin Haematol; 2008 Dec; 21(4):647-58. PubMed ID: 19041604
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effect of glucocorticoids, E. coli- and Erwinia L-asparaginase on hemostatic proteins in children with acute lymphoblastic leukemia.
    Mall V; Thomas KB; Sauter S; Niemeyer CM; Sutor AH
    Klin Padiatr; 1999; 211(4):205-10. PubMed ID: 10472551
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Thrombosis related to the use of L-asparaginase in adults with acute lymphoblastic leukemia: a need to consider coagulation monitoring and clotting factor replacement.
    Alberts SR; Bretscher M; Wiltsie JC; O'Neill BP; Mokri B; Witzig TE
    Leuk Lymphoma; 1999 Feb; 32(5-6):489-96. PubMed ID: 10048421
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 24.